Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge

Clinical and Experimental Allergy

Volumn 27, Issue 9, 1997, Pages 1043-1051

  Brinkman, L ^a   Aslander, M M ^a   Raaijmakers, J A M ^a   Lammers, J W J ^a   Koenderman, L ^a   Bruijnzeel Koomen, C A F M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allergen inhalation challenge; Asthma; Atopic dermatitis; Bronchial hyperresponsiveness

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E; METHACHOLINE; TAR;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; ATOPIC DERMATITIS; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; ECZEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MALE; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; SKIN DEFECT;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; DERMATITIS, ATOPIC; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 0030765951     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01256.x     Document Type: Article

References (36)

1. Queille-Roussel C, Raynaud F, Saurat J-H. A prospective computerized study of 500 cases of atopic dermatitis in childhood. Acta Derm Venereol (Stockh) 1985; Suppl. 114: 87-92.
2. Musgrove K, Morgan JK. Infantile eczema. A long-term follow-up study. Br J Dermatol 1976; 95:365-72.
3. Fabrizi G, Corbo GM, Ferrante E et al. The relationship between allergy, clinical symptoms and bronchial responsiveness in atopic dermatitis. Acta Derm Venereol (Stockh) 1992; Suppl. 176:68-73.
4. Corbo GM, Ferrante E, Macciocchi B et al. Bronchial hyperresponsiveness in atopic dermatitis. Allergy 1989; 44:595-8.
5. Kaliner M. The cholinergic nervous system and immediate hypersensitivity. J Allergy Clin Immunol 1976; 58:308-15.
6. De Monchy JGR, Kauffman HF, Venge P et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373-6.
7. Cockcroft D\V, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79:734-40.
8. Bruijnzeel-Koomen CAFM, Van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells from patients with atopic dermatitis. Arch Derm Res 1986; 278:199-205.
9. Ramb-Lindhauer C, Feldmann A, Rotte M, Neumann C. Characterization of grass pollenreactive T cell lines derived from lesional atopic skin. Arch Derm Res 1991; 283:71-6.
10. Van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991; 97:389-94.
11. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347:15-8.
12. Langeveld-Wildschut EG, van Marion AMW, Thepen T, Mudde GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM. Evaluation of variables influencing the outcome of the atopy patch test. J Allergy Clin Immunol 1995; 96:66-73.
13. Rajka G. Delayed dermal and epidermal reactivity in atopic dermatitis. Acta Derm Venereol (Stockh) 1967; 47:158-62.
14. Butler JM, Peters JE, Hirschman CA, White CR Jr, Margolin LB, Hanifin JM. Pruritic dermatitis in asthmatic basenji-greyhound dogs: a model for human atopic dermatitis. J Am Acad Dermatol 1983; 8:33-8.
15. Chapman MD, Rowntree S, Mitchell EB, Di Prisco de Fuenmajor MC, Platts-Mills TAE. Quantitative assessments of IgG and IgE antibodies to inhalant allergens in patients with atopic dermatitis. J Allergy Clin Immunol 1983; 72:27-33.
16. Leung DYM, Geha RS. Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy 1986; 4:67-86.
17. Brocq L. Conception générale des dermatoses, nouvelle note sur leur classification. Ann Dermatol Syphiligr 1927; 8:65.
18. Rajka G. Clinical aspects. In: Rajka G, éd. Essential aspects of atopic dermatitis. Berlin, Heidelberg: Springer Verlag, 1989, 4-55.
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-44.
20. Quanjer PhH. Standardized lung function testing. Report working party standardization of lung function tests, European community for steel and coal. Eur Respir J 1993; 6, Suppl. 16:5-100.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; Suppl. 92:44-7.
22. Costa C, Rilliet A, Nicolet M, Saurat JH. Scoring atopic dermatitis: the simpler the better? Acta Derm Venereol (Stockh) 1989; 69:41-5.
23. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-43.
24. Sterk PJ, Fabbri LM, Quanjer PhH et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6, Suppl. 16:53-83.
25. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978; 33:705-10.
26. Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987; 135:264-7.
27. Bousquet J, Chanez P, Chanal I, Michel FB. Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. J Allergy Clin Immunol 1990; 85:103943.
28. Platts-Mills TAE, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; ii:675-8.
29. Dohi M, Okudaira H, Sugiyama H et al. Bronchial responsiveness to mite allergen in atopic dermatitis without asthma. Int Arch Allergy Appl Immunol 1990; 92:138-42.
30. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
31. Cockcroft DW. Bronchial inhalation tests II. Measurement of allergic (and occupational) bronchial responsiveness. Ann Allergy 1987; 59:89-98.
32. Ohnishi T, Kita H, Weiler D et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147:901-7.
33. Sedgwick JB, Calhoun WJ, Gleich GJ et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Am Rev Respir Dis 1991; 144:1274-81.
34. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991; 88:637-48.
35. Sur S, Hunt LW, Weiler DA, Ohnishi T, Gleich GJ. In vitro release of eosinophil active cytokines from airway dwelling cells (abstract). J Allergy Clin Immunol 1992; 89:215.
36. Smith DL, Deshazo RD. Bronchalveolar lavage in asthma. Am Rev Respir Dis 1993; 148:523-32.